Our framework successfully supported different types of classification tasks, from strongly supervised to attention-based MIL frameworks, from tumor detection, to prediction of prognostic clinical biomarkers (e.g., TP53 mutation) and risk of cancer-related death. The gene discussed is TP53; the disease is cancer.